The third-quarter earnings season revealed a stark divergence in performance among leading healthcare technology providers. While Omnicell impressed with strong results and a soaring stock, peers like Evolent Health and Astrana Health faced significant market headwinds despite revenue beats.
Honda Motor posted a 4.3% year-on-year increase in global vehicle production for December 2025, recovering from a steep November slump. However, the automaker's full-year 2025 output fell nearly 9%, highlighting uneven regional performance with North America rebounding sharply while Asia, particularly China, saw significant declines.
As warnings mount over loosening lending standards in the booming private credit market, investors are scrutinizing ultra-high-yield BDC stocks. While some show signs of stress, selective opportunities may still exist for those who look beyond the headline yield.
In the aftermath of the devastating '10/10' market crash of 2025, Binance finds its dominance and trust metrics under a microscope. While the exchange compensated users and maintains its user base, questions about systemic risk and centralization linger, shaping the post-crash narrative.
Financial disclosures show the growing religious instruction nonprofit LifeWise Academy increased its fundraising haul last year while its net profit fell, as it expands its reach into public schools across Ohio and nationwide.
As global markets navigate a period of uncertainty, a select group of technology companies across Norway, Sweden, and Israel are posting explosive growth. We examine the financials and strategies behind Appear ASA, Hacksaw AB, and NextVision Stabilized Systems—firms turning innovation into investor returns.
Amid a market environment of stable rates and mixed sentiment, we highlight three companies—spanning biotech, gaming, and tech hardware—whose current share prices appear significantly below their estimated intrinsic value based on cash flow projections.
The UK pharmaceutical giant AstraZeneca begins trading ordinary shares on the New York Stock Exchange today, a significant upgrade from its previous Nasdaq ADR listing. This move underscores the company's strategic rebalancing towards the United States, its largest market, and raises questions about the long-term relevance of its London listing.
While often operating behind the scenes, industrial companies are the engine of the U.S. economy. Bolstered by a favorable interest rate environment, the sector has surged 18.8% in the last six months, significantly outpacing the S&P 500. We analyze two firms with durable competitive edges and one that may be losing momentum.
While recent surges in Trex, Robert Half, and Lemonade have captured investor attention, a closer look reveals valuation concerns and structural challenges that suggest their momentum may be fragile.
As IAC prepares to report quarterly results, investors are bracing for another potential revenue decline. We examine the key metrics, peer performance, and what the numbers could mean for the company's turnaround strategy.
The semiconductor testing equipment leader capitalizes on surging AI chip demand to deliver historic Q3 results, while unveiling a significant treasury share cancellation and business segment reorganization aimed at enhancing shareholder value and operational focus.
Buoyed by robust quarterly and full-year results, Annaly Capital Management is pivoting more capital toward residential credit and mortgage servicing rights. The mortgage REIT's strategic shift aims to build on its earnings momentum while navigating an evolving interest rate landscape.
Immunocore Holdings (IMCR) shares have experienced notable turbulence, declining over 7% in a week. Yet, a significant gap between its current price and analyst fair value estimates highlights a debate over the biotech's future, heavily reliant on its lead asset KIMMTRAK and pipeline execution.
Shares of tower REIT SBA Communications (SBAC) have faced sustained pressure, declining across multiple timeframes. With the stock trading significantly below common fair value estimates, analysts and investors are divided on whether this presents a buying opportunity or reflects deeper sector headwinds.
Walmart appoints veteran executive John Furner as its new chief executive, placing digital transformation, artificial intelligence, and expanded health services at the forefront of its growth strategy.
LinkedIn co-founder Reid Hoffman argues that AI-native startups, by building custom solutions for precise problems, are enabling tiny teams to achieve output once requiring ten times the headcount, fundamentally reshaping productivity and competition.
Thiel Macro, the hedge fund managed by Palantir co-founder Peter Thiel, has made a decisive shift in its investment strategy, exiting Nvidia and reducing Tesla while building massive positions in Apple and Microsoft, which together now constitute over 60% of its holdings.
W.R. Berkley's Q4 earnings presented a mixed picture, meeting profit forecasts but missing on revenue. While management highlighted disciplined underwriting and tech-driven efficiency, analysts probed deeper into the challenges of competition, pricing, and strategic adaptation in a shifting market.
Hospitality tech provider Agilysys saw its stock price drop sharply post-earnings, even as Q4 revenue topped estimates. Higher development costs squeezed profits, though CEO highlighted strong subscription growth in key segments. Analysts are now scrutinizing the pace of major rollouts and efficiency gains.
